ニコチンの精神薬理学<br>Nicotine Psychopharmacology (Handbook of Experimental Pharmacology) 〈Vol. 192〉

個数:

ニコチンの精神薬理学
Nicotine Psychopharmacology (Handbook of Experimental Pharmacology) 〈Vol. 192〉

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 544 p./サイズ 56 b/w illus.
  • 言語 ENG
  • 商品コード 9783540692461
  • DDC分類 615.785

基本説明

ニコチンの精神薬理学の、分子から臨床、疫学的な側面まで各種の研究論文を収録。

Full Description

The fact that tobacco ingestion can affect how people feel and think has been known for millennia, placing the plant among those used spiritually, honori?cally, and habitually (Corti 1931; Wilbert 1987). However, the conclusion that nicotine - counted for many of these psychopharmacological effects did not emerge until the nineteenth century (Langley 1905). This was elegantly described by Lewin in 1931 as follows: "The decisive factor in the effects of tobacco, desired or undesired, is nicotine. . . "(Lewin 1998). The use of nicotine as a pharmacological probe to und- stand physiological functioning at the dawn of the twentieth century was a landmark in the birth of modern neuropharmacology (Limbird 2004; Halliwell 2007), and led the pioneering researcher John Langley to conclude that there must exist some "- ceptive substance" to explain the diverse actions of various substances, including nicotine, when applied to muscle tissue (Langley 1905). Research on tobacco and nicotine progressed throughout the twentieth century, but much of this was from a general pharmacological and toxicological rather than a psychopharmacological perspective (Larson et al. 1961). There was some attention to the effects related to addiction, such as euphoria (Johnston 1941), tolerance (Lewin 1931), and withdrawal (Finnegan et al. 1945), but outside of research supported by the tobacco industry, addiction and psychopharmacology were not major foci for research (Slade et al. 1995; Hurt and Robertson 1998; Henning?eld et al. 2006; Henning?eld and Hartel 1999; Larson et al. 1961).

Contents

Nicotine and Tobacco Consumption: Measurement and Trends.- Global Patterns of Nicotine and Tobacco Consumption.- Nicotine Chemistry, Metabolism, Kinetics and Biomarkers.- Nicotine Content and Delivery Across Tobacco Products.- Nicotine Pharmacology and Mechanisms of Action.- The Road to Discovery of Neuronal Nicotinic Cholinergic Receptor Subtypes.- Magnetic Resonance Imaging Studies of Cigarette Smoking.- In vivo Brain Imaging of Human Exposure to Nicotine and Tobacco.- Molecular and Cellular Mechanisms of Action of Nicotine in the CNS.- The Neuronal Pathways Mediating the Behavioral and Addictive Properties of Nicotine.- Molecular Genetics of Nicotine Metabolism.- Sex Differences in Nicotine Action.- Nicotine Psychopharmacology.- Recognising Nicotine: The Neurobiological Basis of Nicotine Discrimination.- Effects of Nicotine in Experimental Animals and Humans: An Update on Addictive Properties.- Discriminative Stimulus Effects of Nicotine in Humans.- Rodent Models of Nicotine Withdrawal Syndrome.- Approaches, Challenges, and Experience in Assessing Free Nicotine.- Approaches, Challenges, and Experience in Assessing Free Nicotine.- Tobacco Industry Manipulation of Nicotine Dosing.- Pharmacotherapy for Tobacco Dependence.- Nicotine Psychopharmacology: Policy and Regulatory.